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Introduction: We have recently found that miR-17 is necessary in the cell-extrinsic control of cord blood (CB)
CD34+ cell function. Here, we demonstrated that the proper level of miR-17 is also necessary in the cell-intrinsic
control of the hematopoietic properties of CB CD34+ cells.
Methods: The miR-17 overexpression and knockdown models were created using primary CB CD34+ cells
transfected by the indicated vectors. Long-term culture, colony forming, adhesion and trans-well migration assays
were carried out to investigate the function of miR-17 on CB CD34+ cells in vitro. NOD prkdcscid Il2rgnull mice were
used in a SCID repopulating cell assay to investigate the function of miR-17 on CB CD34+ cells in vivo. A two-tailed
Student’s t-test was used for statistical comparisons.
Results: In vitro assays revealed that ectopic expression of miR-17 promoted long-term expansion, especially in the
colony-forming of CB CD34+ cells and CD34+CD38− cells. Conversely, downregulation of miR-17 inhibited the
expansion of CB CD34+ cells. However, the overexpression of miR-17 in vivo reduced the hematopoietic
reconstitution potential of CB CD34+ cells compared to that of control cells. The increased expression of major
adhesion molecules in miR-17 overexpressed CB CD34+ cells suggests that the adhesion between miR-17
overexpressed CB CD34+ cells and their niche in vivo is regulated abnormally, which may further lead to the
reduced hematopoietic reconstitution capability of 17/OE cells in engrafted mice.
Conclusion: We conclude that the proper expression of miR-17 is required, at least partly, for normal hematopoietic
stem cell–niche interaction and for the regulation of adult hematopoiesis.Introduction
Hematopoiesis is a process capable of generating up to
300 million cells per minute in the bone marrow of an
adult human [1]. All these cells arise from multipotent
hematopoietic stem cells (HSCs) [2]. Continuous blood
cell production for life is achieved by balancing self-
renewal and differentiation among proliferating HSCs.
This inner balance between self-renewal and lineage
commitment is tightly controlled by integrating intrinsic
and extrinsic mechanisms that govern the HSC state,
which are still currently ambiguous [3–6].
MicroRNAs (miRNAs) are short non-coding RNAs
(21 to 23 nucleotides in length) and are postulated to
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important biological roles of miRNAs on hematopoiesis
have been studied either by complete inactivation of
miRNA formation or by selective targeting of specific
miRNAs by many research groups. All of these studies
suggest a major role for miRNAs in the regulation of
hematopoietic cell commitment, proliferation, apoptosis,
survival, and differentiation [10–13]. Recently, some miR-
NAs have been investigated in murine HSCs. Ectopic ex-
pression of miR-181 in lineage negative hematopoietic
progenitor cells from mouse bone marrow increased the
fraction of B lineage cells (CD19+) in vitro and in vivo
[14]. Enforced expression of miR-29a induced aberrant
self-renewal in downstream progenitors, resulting in a
low penetrant acute myeloid leukemia disease [15].
miR-17-92 cluster increasing expands multipotent
hematopoietic progenitors, while imbalanced expres-
sion of its individual oncogenic miRNAs promotess distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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but not granulocyte colony-stimulating factor-induced
granulocytic differentiation, and enforced expression
of miR-125b induced an initial myeloproliferative dis-
order depending upon the ectopic expression levels
[17–19]. Collectively, these studies indicate that miR-
NAs may be important regulators of hematopoiesis.
miR-17 (also called miR-17-5p), an important member
of the miR-17-92 cluster, contains the AAAGUGC-seed
sequence [20]. miR-17 is abundantly expressed in mur-
ine hematopoietic progenitors and increased expression
of AAAGUGC-seed containing miRNA in lineage nega-
tive bone marrow cells promotes replating capacity and
expansion of myeloid progenitors [21]. However, accord-
ing to the model for HSC/hematopoietic progenitor cell
(HPC)-expressed miRNA-mediated control of human
hematopoiesis predicted by Georgantas et al., ectopic ex-
pression of miR-17 in peripheral blood cells may inhibit
both myeloid and erythroid colony growth [22]. Fontana
et al. reported that downregulation of the miR-17-92
cluster can promote myeloid lineage fate, which is in line
with the prediction of Georgantas et al. [23]. Moreover,
Li et al. showed that the miR-92a-induced erythroleuke-
mia cell line, when overexpressing miR-17, displayed a
significantly reduced proliferation rate, exhibited mor-
phological features of apoptosis, and ultimately died
2 weeks post-transduction [16]. Although these studies
all indicate that miR-17 is an important regulator of
hematopoiesis, the function of miR-17 on hematopoiesis
remains controversial. Moreover, most of the data about
miR-17 to date were obtained from murine studies
while the relevance to human HSC still needs to be
substantiated.
Recently, we have found that miR-17 is necessary in
the cell-extrinsic control of HSC and HPC function,
which is, at least in part, through the augmented HIF-1α
signal pathways in osteoblasts [24]. Here, we reported
that miR-17 is also necessary in the cell-intrinsic control
of governing the biological properties of human cord
blood (CB) CD34+ cells in vitro and in vivo. Our data
showed that miR-17 is significantly expressed in human
CB CD34+CD38− cells compared to the levels expressed
in the CD34+CD38+ cells or mononuclear cells (MNCs).
By overexpression and knockdown studies, we showed
that ectopic expression of miR-17 promotes long-term
expansion and colony forming of CB CD34+ cells and
CD34+CD38− cells in vitro. Knockdown of miR-17, on
the other hand, resulted in decreased CB CD34+ cell ex-
pansion, which consequently diminished the cell num-
ber. However, it is to be noted that the hematopoietic
reconstitution potential of miR-17-overexpressed CB
CD34+ cells in vivo were significantly reduced in con-
trast with that of control CB CD34+ cells in repopulating
assays with NPG mice. We further found that theexpression of selected major adhesion molecules on CB
CD34+ cells was increased and the specific adhesion of
these cells to N-cadherin and vascular cell adhesion
molecule-1 (VCAM1) were also enhanced upon miR-17
overexpression in vitro. The adhesion potential of 17/OE
CB CD34+ cells to VCAM1 was significantly reduced
following β1-integrin knockdown, which suggested that
β1-integrin expressed on 17/OE CD34
+ cells mediated,
at least in part, the increase in interaction between
17/OE CD34+ cells and VCAM1 caused by ectopic
miR-17. Our data imply that the adhesion between
miR-17-overexpressed CB CD34+ cells and their niche
in vivo is regulated abnormally, which may further
lead to the reduced hematopoietic reconstitution cap-
ability of 17/OE cells in engrafted mice.
Materials and methods
Cell cultures
Human CB samples were obtained as described previously
[24, 25]. After isolation by lymphocyte separation medium
(TBD Biotech, Tianjing, China), CB MNCs were immuno-
magnetically enriched for CD34+ cells using the MACS
CD34+ Progenitor Cell Isolation Kit (Miltenyi Biotech
Inc., Bergisch Gladbach, Germany) according to the manu-
facturer’s instructions. The purity of CD34+ cells was about
80–90 %, as determined by flow cytometry. CB CD34+
cells were resuspended and stained with CD38 (Miltenyi
Biotech Inc.) in phosphate-buffered saline with 2 % fetal
calf serum to obtain CD34+CD38−/CD38+ cells. Subse-
quent expansion of CD34+ cells or CD34+CD38−/CD38+
cells (1.0 × 104/well) was carried out in StemSpan SFEM II
(Stem Cell Technologies, Vancouver, BC, Canada), supple-
mented with 2 mM L-glutamine, 100 U/ml penicillin/
streptomycin and a cytokine cocktail consisting of Flt
ligand (25 ng/ml), SCF (25 ng/ml), thrombopoietin
(25 ng/ml), and interleukin-6 (25 ng/ml) (Peprotech
Inc., NJ, USA). After the indicated days of culture, the
cells were collected by gentle pipetting from the culture
and were used for further assessment. This study was
approved by the Ethics Committee of Peking University.
Before the experiments, the subjects were informed of
the objectives, requirements and procedures of the ex-
periments. All subjects gave informed written consent
to participate in the study.
Vector generation and transfection
The two miR-17-specific small hairpin RNAs (17/KD and
17/KD1) [24] and β1-integrin-specific shRNA (β1/KD) olig-
omers [26] were tested. Briefly, double-stranded DNA
oligonucleotides were chemically synthesized and inserted
into the pSUPER vector. Inserts were confirmed by sequen-
cing. pSUPER vectors containing green fluorescent protein
(GFP) and the indicated inserts were transfected into
CD34+ cells by Lipofectanine 2000 (Invitrogen, CA, USA)
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mentioned, pSUPER vectors containing scrambled target
sequences not complementary to any known miRNA were
served as controls for 17/KD (CTRL).
The human pre-miR-17 gene was amplified by poly-
merase chain reaction (PCR) and subcloned into the
vector pCMV-GFP to generate the expression constructs
pCMV-GFP-pre-miR-17 (17/OE). Vectors containing the
empty intron sequence served as controls for 17/OE
(CTRL). Isolated CD34+ cells were cultured in Stem-
Span medium with the same supplements and cytokines
as mentioned above. After 12–18 hours of culture, cells
were transfected with the vectors. After FACS sorting
with the FITC channel, the proportion of GFP-positive
CD34+ cells reached 90 % 48 hours after transfection.
RNA extraction and real-time PCR
Total RNA was extracted using the total RNA kit I
(OMEGA, GA, USA). The first-strand cDNA was synthe-
sized by the miRcute miRNA First-Strand cDNA Synthesis
Kit (TIANGEN, BJ, China). Real-time PCR analysis was
performed by ABI7500 (Applied Biosystems, CA, USA)
using the miRcute miRNA qPCR Detection Kit (SYBR
Green; TIANGEN). U6 snRNA (for miRNA) was used as
the endogenous control. All samples were done in tripli-
cate. The relative expression was determined using the
ΔΔCT method.
Colony forming cell assay
Human colony forming cell assays were performed at
day 7 or 14 of culture in a MethoCult GF H4434
“Complete” Methylcellulose medium with recombinant
cytokines from Stem Cell Technologies. After 14–16
days of culture, colony-forming units (CFU-Cs) and
lineage-specific colonies including colony-forming unit-
erythrocyte (BFU-Es), colony-forming unit-granulocyte-
macrophages (CFU-GMs), and colony-forming unit-mix
(CFU-Mix’s), were counted under an inverted micro-
scope and identified according to the manufacturer’s
instructions.
Antibodies
The following antihuman antibodies were used for flow
cytometric analysis or sorting: CD38-APC (allophyco-
cyanin), CD34-PE (phycoerythrin), N-cadherin-APC,
β1-integrin-APC, CD44-APC, CXCR4-APC and CD49-
APC (obtained from BD Biosciences, CA, USA). Each
sample was blocked with 0.1 % bovine serum albumin in
phosphate-buffered saline before staining. APC- or PE-
conjugated mouse IgG1 (BD Biosciences) were used as
isotype controls. Blocking antibody to CD29 (VLA4)
was purchased from R&D Systems (Minneapolis, MN,
USA). The anti-N-cadherin (GC-4) antibody was pur-
chased from Sigma (St Louis, MO, USA). All antibodyblocking treatments and staining were carried out for
40 minutes on ice.SCID repopulating cell assay
SCID repopulating cell assay was carried out as de-
scribed previously [24]. Briefly, CB CD34+ cells were
transfected, harvested as described above, and injected
intravenously into 8-week-old, sublethally irradiated
(1.8 Gy) NOD prkdcscid Il2rgnull (NPG™, Vitalstar, Beijing,
China) mice. The mice transplanted with freshly isolated
CD34+ cells were used as positive controls. The mice were
temporally monitored for 20 weeks and the peripheral
blood (PB) was obtained through nonlethal eyebleeds
under anesthesia with isoflurane as per institutional guide-
lines every 4 weeks. The mice were sacrificed at 20 weeks.
Bone marrow MNCs were harvested and analyzed by flow
cytometry. Human cell reconstitution was assessed using
CD45, CD34, CD36, and GPA markers. Mouse IgG1 con-
jugated to PE, APC or PC7 were used as isotype controls.
PCR amplification of the human 17α-satellite gene was
employed as a second test for the presence of human cells
in the NPG mice that had received transplants. All care
and handling of animals was performed with the approval
of the Institutional Authority for Laboratory Animal Care
of Peking University.Adhesion and trans-well migration assays
Adhesion assay was carried out in a 48-well plate [27, 28].
Prior to use, wells were coated with ligands (N-cadherin
5 μg/ml, VCAM1 10 μg/ml) at 4 °C overnight. Super-
natant was aspirated and wells were then incubated
with 1 % bovine serum albumin for 30 minutes. Fol-
lowing incubation, CB CD34+ cells (5.0 × 104 cells/well),
resuspended in IMDM containing 2 % fetal calf serum,
were added in each well and incubated for 90 minutes
at 37 °C. After removing the nonadhering cells, the
number of adhering hematopoietic cells was deter-
mined by colony-forming cell (CFC) assays at 37 °C
with 5 % CO2 after 14–16 days of culture per experi-
ment. Corresponding controls were also preformed for
each condition.
Chemotactic responses of CD34+ cells to stromal de-
rived factor 1 (SDF1α) were assessed in vitro by trans-
well migration assay [28]. Briefly, 1.0 × 105 of CD34+
cells were plated into the upper chamber of the trans-
well. SDF1α (100 ng) was added to the lower wells con-
taining 600 μl of medium. The bubbles in the wells
were removed gently. For each experimental set, some
wells were kept without SDF1α to detect the spontan-
eous migration. The cells were allowed to migrate for
5 hours at 37 °C. After removing the upper wells, the
migrated cells in the lower wells were collected and
manually counted.
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The results are expressed as the mean ± standard devi-
ation (SD). Statistical comparisons were performed using
a two-tailed Student’s t-test.
Results
The expression levels of miR-17 in CD34+CD38− cells are
higher than those in CD34+CD38+ cells
To determine the expression level of miR-17 in human
hematopoietic cells, we first obtained two populations
from human CB MNCs through the analyses of human
lineage-specific CD markers. The CD34+CD38− popula-
tions expressed significantly higher levels of miR-17 in
comparison to those of the CD34+CD38+ populations or
MNCs (Fig. 1a). The miR-17 levels of the CD34+CD38+
populations showed a tendency, albeit insignificant, to
be higher than those of the MNCs. The expression pat-
tern of miR-17 in human hematopoietic cells is consist-
ent with that in 32D-CSF3R cells [21]. Collectively, miR-
17 levels are downregulated during the differentiation of
human hematopoietic cells, which suggests that miR-17
may play a role in regulating HSC function. To analyze
the function of miR-17 on primitive human hematopoietic
cells, the miR-17 overexpression (17/OE) and knockdown
(17/KD or 17/KD1) models were created using primary
CB CD34+ cells. The expression levels of miR-17 were up-
or downregulated in 17/OE and 17/KD, respectively
(Fig. 1b) compared to those in CTRL. The levels of over-
expression or knockdown 5 days or 20 days after cultureFig. 1 The expression of miR-17 in CB hematopoietic CD34+CD38−/CD38+
was evaluated by real-time PCR. Each reaction was performed in triplicate.
indicated populations. b Real-time PCR was performed to evaluate the exp
for miR-17 overexpression (17/OE), miR-17 knockdown (17/KD or 17/KD1), o
(relative to U6) in 17/OE, 17/KD or 17/KD1 to that in CTRL. Each reaction w
CD34+ cells or 17/KD CD34+ cells 5 days after sorting was evaluated by rea
−/CD38+ cells or 17/KD CD34+CD38−/CD38+ cells 20 days after culture wasin 17/OE CD34+CD38−/CD38+ cells or 17/KD CD34+
CD38−/CD38+ cells were also checked, which main-
tained similar modulation (Fig. 1c and d). Based on
shRNA influence on miR-17 expression in CB CD34+
cells, 17/KD was chosen for further studies.
The transfection efficiency of vectors containing the pre-
miR-17 gene or shRNA specific for miR-17 in CB CD34+
cells was measured by the expression of GFP (Additional
file 1: Figure S1), which were evaluated under inverted
fluorescence microscopy. Transfection in CB CD34+ cells
was positive 24 hours after transfection. The proportion of
GFP-positive CB CD34+ cells after FACS sorted with FITC
channel reached 90 % 48 hours after transfection.
miR-17 promotes expansion and colony forming of CB
CD34+ cells
We then investigated the ability of miR-17 modulation
to expand CB CD34+ cells in vitro. CD34+ cells were
cultured in cytokine-driven serum-free medium. After
20 days of culturing, the number of total cells was
counted. As shown in Fig. 2a, CD34+ cells were ex-
panded significantly upon ectopic miR-17. After knock-
down of miR-17, there was a trend toward a decrease in
the total number of CD34+ cells, although statistical ana-
lyses of the cohort indicated that it did not meet statis-
tical significance (p > 0.05). In order to assess whether
there is a different response between CD34+CD38−
populations and CD34+CD38+ populations upon miR-
17 modulation, the expansion curves from the twocells. a The expression level of miR-17 in CB CD34+CD38−/CD38+ cells
Student’s t-test was used for the statistical analysis between the two
ression level of miR-17 in CB CD34+ cells after transfection with vectors
r control (CTRL). The data are presented as the ratio of miR-17 levels
as performed in triplicate. c The expression level of miR-17 in 17/OE
l-time PCR. d The expression level of miR-17 in 17/OE CD34+CD38
evaluated by real-time PCR
Fig. 2 The effect of miR-17 modulation on the expansion of CB CD34+CD38−/CD38+ cells. a The expansion of CB CD34+ cells upon miR-17
modulation after culturing for 20 days. CB CD34+ cells were transfected with vectors for miR-17 overexpression (17/OE), miR-17 knockdown (17/KD), or
control (CTRL) and cultured in cytokine-driven serum-free medium. Fold expansion is shown as mean + SD (n = 6). *p < 0.05, between 17/OE or 17/KD,
and CTRL group (Student’s t-test). b CB CD34+ cells, transfected with ectopic miR-17 vector (17/OE or 17/KD), were further separated through the
analysis of CD38 expression. Cells were cultured in cytokine-driven serum-free medium and the cell numbers were monitored. The data are presented
as the fold expansion (n = 6, mean + SD). *p < 0.05; **p < 0.01, between 17/OE or 17/KD and CTRL group (Student’s t-test). c Colony forming assays of
CB CD34+ cells upon miR-17 modulation. After 7 or 14 days of culture, the indicated cell numbers were plated for colony forming assays. The colonies,
including BFU-Es, CFU-GMs, and CFU-Mix’s, with greater than 50 cells were counted after 14–16 days. The results are expressed as mean + SD (n = 6).
*p < 0.05, between 17/OE or 17/KD, and CTRL group (Student’s t-test). CFU colony forming unit
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shown in Fig. 2b, although both CD34+CD38− and
CD34+CD38+ cells were expanded to different extents
upon miR-17 modulation, the ectopic miR-17 tends to
expand CD34+CD38− cells more, rather than CD34
+CD38+ cells, especially during the first 15 days. The
expansion fold of CD34+CD38− cells from the 17/OE
cells after being cultured for 15 days was significantly
higher than that from the CTRL cells, especially during
the first 5 days. Despite the presence of the HSC-
supporting cytokines, CD34+CD38− cells may undergo
differentiation and become more committed along
with culturing in vitro. Ectopic miR-17 in CD34+ cells
preferentially supports a specific expansion of the
CD34+CD38− populations, especially during the first
5 days, suggesting that the ectopic miR-17 may specifically
affect the least differentiated cells that have the character-
istics of stem or early progenitor cells. After knockdown
of miR-17, there was a trend toward a decrease in the ex-
pansion capacity of CD34+CD38−/CD38+ cells, althoughstatistical analyses of the cohort indicated that it did not
meet statistical significance (p > 0.05) outside of the first
5 days from CD34+CD38− cells. Taken together, these data
indicate that the ectopic miR-17 in CD34+ cells preferen-
tially supports a specific expansion of the CD34+CD38−
populations in vitro.
To investigate whether the expanded CB CD34+ cells after
miR-17 modulation maintained multipotent differentiation
of HSC, we performed colony forming assays. CB CD34+
or CD34+CD38− cells after transduction were cultured for
7 or 14 days in cytokine-driven serum-free medium and
then subject to a CFU assay. After 14–16 days of culture,
the colonies with greater than 50 cells were counted under
an inverted microscope (Additional file 1: Figure S1). As
shown in Fig. 2c, the number of total CFUs and CFU-GM
from the 17/OE cells after being cultured for 7 days in vi-
tro was significantly higher than that from CTRL. The
number of CFU-Mix and BFU-E did not change signifi-
cantly after miR-17 overexpression. Knockdown of miR-17
in CD34+ cells, on the other hand, resulted in reduced
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significantly diminishing CFC and CFU-GM output
(Fig. 2c). We further examined the multipotent differen-
tiation of CD34+CD38−/CD38+ cells upon miR-17
modulation after cultured for 14 days in vitro. Compared
with that from CD34+ cells after culturing for 7 days,
there was a significant increase in the number of CFU-
Mix from CD34+CD38− cells upon miR-17 overexpres-
sion (Fig. 2c). After knockdown of miR-17, there was a
trend toward a decrease in the colony forming capacity
of CD34+CD38−/CD38+ cells, although statistical ana-
lyses of the cohort indicated that it did not meet statis-
tical significance (p > 0.05) outside of the CFU-GM
forming capacity from CD34+CD38− cells. Together, our
data suggest that miR-17 in CD34+ cells preferentially
promotes a specific expansion of the CB CD34+CD38−
populations in vitro and the expanded CD34+CD38−
cells could differentiate into all of the lineages tested.
Effects of miR-17 modulation on the hematopoietic
reconstitution capability of CB CD34+ cells in NPG mice
To further support our in vitro expansion results, we ex-
amined the hematopoietic reconstitution potential of CB
CD34+ cells after miR-17 modulation in NPG mice. The
sublethally irradiated NPG mice were transplanted with
4.0 × 104 CB 17/OE CD34+ cells, CTRL, or CB 17/KD
CD34+ cells using intravenous injection. We temporally
monitored the PB of NPG recipients transplanted with
miR-17-modulated CB CD34+ cells for 20 weeks by ana-
lyzing the percentage of human CD45+ cells using flow
cytometry every 4 weeks. Although the percentage of
human CD45+ cells gradually increased in the PB from
all of the mice transplanted with miR-17-modulated CB
CD34+ cells, the PB from 17/KD recipients displayed a
significantly higher percentage of human CD45+ cells
at 4 weeks than CTRL recipients, indicating that the
hematopoietic reconstitution potential of 17/KD CD34+
cells is higher than that of CTRL CD34+ cells during the
first 4 weeks (Fig. 3a left panel). The percentage of hu-
man CD45+ cells in the PB from the 17/OE or 17/KD
group showed a tendency, although insignificant, to be
lower than that from the CTRL group at 20 weeks after
transplantation. The levels of total human cell engraft-
ment composed of CD45+, CD45−CD36+ and CD36−GPA+
cells, and CD45+CD34+ populations were assessed in the
bone marrow MNCs of the engrafted mice at 20 weeks
post-transplant using flow cytometry. At 20 weeks, the
amount of total human cells in the mice injected with
17/OE CD34+ cells or 17/KD CD34+ cells was signifi-
cantly lower than that of the mice injected with CTRL
CD34+ cells (Fig. 3a middle panel; p < 0.03 and 0.04, re-
spectively), which indicates that the hematopoietic re-
constitution ability of 17/OE CD34+ cells and 17/KD
CD34+ cells is reduced in comparison with that ofCTRL CD34+ cells. The statistical analysis was per-
formed by comparing the mice injected with 17/OE or
17/KD CD34+ cells to those injected with CTRL cells.
We further analyzed the multilineage development from
the input CB CD34+ cells. Flow cytometry analysis of
the human graft in a representative engrafted mouse
from each group is shown in Fig. 3b. There was no sig-
nificant difference in the percentage of erythroid cells,
including CD45−CD36+ and CD36−GPA+ populations
upon comparing the 17/OE or 17/KD group with the
corresponding CTRL group (Fig. 3a right panel). How-
ever, we observed a significantly lower percentage of
CD45+ cells in the 17/OE group compared to that in the
CTRL group. Similarly, in contrast to the CTRL group,
the 17/OE group also showed a significantly lower per-
centage of CD45+CD34+ cells (Fig. 3a right panel). The
percentage of CD45+CD34+ cells in the 17/KD group
whose transplants of CD34+ cells with miR-17 knock-
down showed a tendency, although insignificant, to be
lower than that of mice receiving transplants of CTRL
CD34+ cells. The observed multilineage development
from input 17/KD CD34+ populations partly coincides
with the results of expansion and colony forming assays
in vitro. However, when the input cell numbers were
similar, the 17/OE CD34+ cells contributed significantly
less to hematopoietic reconstitution in recipient mice as
opposed to the CTRL CD34+ cells, which was different
from the in vitro expansion and colony forming assay,
suggesting that the hematopoietic reconstitution capability
of miR-17-overexpressed CB CD34+ cells were reduced
in vivo. To confirm whether this inconsistency resulted
from the change of miR-17 expression in vivo, we checked
the levels of miR-17 expression in GFP-positive cells from
engrafted mice at 20 weeks. As shown in Fig. 3c, the ex-
pression levels of miR-17 were still up- or downmodulated
in GFP-positive cells from NPG recipients transplanted
with CB 17/OE CD34+ cells or 17/KD CD34+ cells, re-
spectively, although the expression levels of miR-17 be-
came somewhat lower compared to that of corresponding
initial cells. To further confirm that the human cells deter-
mined by flow cytometry were of human origin, the
human-specific 17α-satellite gene was detected using PCR
in several representative engrafted mice, which contained
different percentages of human cells. We found that the
human 17α-satellite gene could be detected by PCR ampli-
fication when the percentage of human cells was over
0.50 % (Fig. 3d, lanes 3–5), whereas it was undetectable at
a percentage of 0.21 % (Fig. 3d, lane 2).
The expression of adhesion molecules on CB CD34+ cells
upon miR-17 modulation
Ectopic miR-17 promotes the expansion of CB CD34+
cells in vitro but the hematopoietic reconstitution cap-
ability of 17/OE cells is reduced in vivo, which displays
Fig. 3 Effect of miR-17 modulation on the hematopoietic reconstitution potential of CB CD34+ cells in NPG mice. a Effect of miR-17 modulation
on repopulation of CB CD34+ cells in NOD prkdcscid Il2rgnull (NPG™) mice. 4.0 × 104 miR-17 overexpression (17/OE), miR-17 knockdown (17/KD), or
control (CTRL) CB CD34+ cells were injected intravenously into the sublethally irradiated NPG mice (n = 6 per group). The PB of NPG recipients
was temporally monitored by analyzing CD45+ population every 4 weeks. The mice were sacrificed at 20 weeks after transplantation and the
mononuclear cells from bone marrow were analyzed for human cells composed of CD45+, CD45−CD36+ and CD36−GPA+ cells and CD45+CD34+
population by flow cytometry. The level of total human cell engraftment is shown in the left panel. p < 0.03 or 0.04, between the NPG mice
injected with 17/OE or 17/KD CD34+ cells and those injected with CTRL cells (Student’s t-test). The fraction of CD45+, erythroid (CD45−CD36+ and
CD36−GPA+) and CD45+CD34+ population among the engrafted human cells is shown in the middle panel. The percent of CD45+ cells of PB
from NPG recipients was shown in the right panel. *p < 0.05, between the NPG mice injected with 17/OE or 17/KD CD34+ cells and those
injected with CTRL cells (Student’s t-test). The significant difference was analyzed between the mice injected with 17/OE or 17/KD CD34+ cells
and those injected with CTRL cells. b Flow cytometry analysis of the human CB CD34+ cell repopulation in a representative NPG mouse after
miR-17 modulation. Fresh CD34+ cells served as controls. The MNCs from bone marrow harvested from the engrafted NPG mice were examined
by flow cytometry for the assessment of human cells composed of CD45+ cells (R1), erythroid cells including CD45−CD36+ (R2) and CD36−GPA+
(R3) populations and CD45+CD34+ cells (R4). c The levels of miR-17 expression in GFP-positive cells from engrafted mice at 20 weeks were tested
by real-time PCR. d The bone marrow MNCs containing the different percentage of human cells (lanes 2–5) from the representative engrafted
mice were analyzed for human-specific 17α-satellite DNA by PCR. The human-specific 17α-satellite gene was detected when the human cells
were over 0.50 % (lanes 3–5) whereas it was indetectable at a percentage of 0.21 % (lane 2). Lane 1, one mouse without transplants; lane 2, one
mouse receiving transplants of 17/OE CD34+ cells; lane 3, one mouse receiving transplants of 17/KD CD34+ cells; lane 4, one mouse receiving
transplants of CTRL CD34+ cells; lane 5, one mouse receiving transplants of fresh CD34+ cells
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constitution capability of engrafted hematopoietic cells is
also affected by the components from a physiological
niche where HSCs reside in vivo. Successful hematopoietic
reconstitution of human hematopoietic cells in engrafted
mice needs proper proliferation, suitable attachmentbetween HSCs and the bone marrow niche, as well as mi-
gration of HSCs in vivo. To examine whether the reduced
hematopoietic reconstitution capability of CB CD34+ cells
upon miR-17 modulation in vivo is a result of improper
attachment or migration in engrafted mice, we examined
the expression patterns of selected adhesion and homing
Yang et al. Stem Cell Research & Therapy  (2015) 6:168 Page 8 of 12molecules known to be important for the hematopoietic
reconstitution of human HSCs in the engrafted mice. As
shown in Fig. 4a, 17/OE cells showed significantly higher
expression levels of N-cadherin (3.16 ± 0.82-fold, n = 4) as
well as β1-integrin (3.30 ± 0.98-fold, n = 4) compared to
CTRL cells. We also analyzed the expression of α4 and α5
integrins in 17/OE cells, which were shown to be slightly
increased. The expression levels of CD44 and CXCR4
were almost unchanged upon ectopic miR-17 (Fig. 4b).
The improper expression of N-cadherin and β1-integrin
on CD34+ cells upon miR-17 overexpression raised the
possibility that the adhesion between 17/OE cells and
their niche in vivo is regulated abnormally, which further
leads to the reduced hematopoietic reconstitution capabil-
ity of 17/OE cells in vivo. After knockdown of miR-17,
there was a trend towards a decrease in the expression of
β1-integrin and N-cadherin (Additional file 2: Figure S2) ,
although statistical analyses of the cohort indicated that it
did not meet statistical significance (p > 0.05).
Ectopic expression of miR-17 alters CB CD34+ cell
adhesion to hematopoietic niche components
Through adhesion to the corresponding components
from niche in vivo, the adhesive moleculars expressed byFig. 4 The adhesion molecule expression on CB CD34+ cells after miR-17 o
CD34+ cells after miR-17 overexpressing (17/OE) or control (CTRL) cells was
mean ± SD from multiple independent experiments (right panels). b Flow c
and CXCR4 on miR-17 overexpressing CB CD34+ cells (green and blue lines)hematopoietic cells regulated the interaction between
hematopoietic cells and their niche. To examine whether
the reduced hematopoietic reconstitution ability of 17/OE
cells is related to the upregulated expression of N-
cadherin and β1-integrin, we performed the adhesion
assays in vitro. After incubation with the coated li-
gands, CB CD34+ cells showed a significant increase in
the adhesion to N-cadherin or VCAM1 upon ectopic
miR-17 according to the CFC output (Fig. 5a). In order
to identify whether the increase in adhesion potential
of 17/OE cells to VCAM1 in vitro is directly from the
altered expression levels of β1-integrin in 17/OE cells,
we further knocked down the expression of β1-integrin
in 17/OE cells with β1-integrin-specific shRNA (here
called β1/KD; Fig. 5b). The adhesion potential of 17/OE
CD34+ cells to VCAM1 was significantly blocked upon
β1-integrin knockdown (Fig. 5b), which suggested that
β1-integrin expressed on 17/OE CD34
+ cells mediated,
at least in part, the increase in interaction between 17/
OE CD34+ cells and VCAM1 caused by ectopic miR-17.
In order to demonstrate that the observed adhesion be-
tween 17/OE cells and N-cadherin or VCAM1 was dir-
ectly mediated by their corresponding ligands, the cells
were pre-incubated with soluble anti-N-cadherinverexpression. a The expression of N-cadherin and β1-integrin on CB
analyzed by flow cytometry (left panels). The results are expressed as
ytometry analysis of the expression of α4-integrin, α5-integrin, CD44
and CTRL CD34+ cells (red line)
Fig. 5 Effects of miR-17 overexpression on adhesion and migration of CB CD34+ cells. a The adhesion of miR-17 overexpressing (17/OE) CB CD34+
cells to N-cadherin or vascular cell adhesion molecule-1 (VCAM1) was significantly increased compared with that of control (CRTL) cells.
Results are shown as mean + SD (n = 8 for N-cadherin and n = 10 for VCAM1). *p < 0.05, between 17/OE and CTRL groups (Student’s t-test).
b The adhesion of 17/OE CD34+ cells with β1-integrin deficient (β1/KD) to VCAM1 was significantly decreased compared with that of CRTL
cells. Mean + SD is shown (*p < 0.05, Student’s t-test). The CTRL is 17/OE CD34+ cells with scrambled shRNA. c The specific adhesion of CD34+
cells to N-cadherin or VCAM1 was confirmed by antibody blocking experiments. The adhesion was measured as described above. The
adhesion of pre-treated cells was significant inhibited compared with that of non-treated cells (*p < 0.05, Student’s t-test). d The migration
of 17/OE CB CD34+ cells towards SDF1α was slightly increased compared with that of CTRL cells, but statistical analyses indicated it did not
meet statistical significance (p > 0.3, Student’s t-test)
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forming adhesive assay. The adhesion potential was deter-
mined as described above. As shown in Fig. 5c, the
specific adhesion of pre-incubated cells to each ligand was
significantly reduced compared with that of nontreated
cells. It is of note that the migration of miR-17 overex-
pressed CB CD34+ cells towards SDF1α was slightly de-
creased compared to that of control cells. However,
statistical analyses of this cohort indicated that it did not
meet statistical significance (Fig. 5d), suggesting that the
reduced hematopoietic reconstitution capability of miR-17
overexpressed CB CD34+ cells in vivo does not result
from the migration defect of transplanted 17/OE cells.
Discussion
The self-renewal and differentiation of HSCs are con-
trolled by the integration of cell-intrinsic and cell-
extrinsic mechanisms, which still needs further research.
Through directly or indirectly altering the expression
levels of multiple genes, miRNAs become attractive can-
didates as HSC regulators. This study establishes thatmiR-17 is differentially expressed in human CB
hematopoietic cells (Fig. 1a), which indicates that miR-
17 may play distinct roles in hematopoietic cells at dif-
ferent developmental stages, although more CD markers
are needed to further identify the subpopulations from
CB CD34+ cells. In contrast to the more committed CB
CD34+CD38+ cells, CB CD34+CD38− populations ex-
press significantly higher levels of miR-17, suggesting
that miR-17 may be a key regulator during the develop-
ment of HSCs. miR-17 has been recognized either as an
onco-miRNA or as a tumor suppressor depending on
the cell type. The more precise subpopulations of hu-
man hematopoietic progenitors were established recently
[29–31] so further studies are still needed to get a more
detailed expression profile of miR-17 in human CB
HSCs based on the more precise hierarchy model.
By overexpression and knockdown studies, we demon-
strated that miR-17 regulates the growth of CB CD34+
cells and CD34+CD38− cells in vitro. Ectopic expression
of miR-17 resulted in the promoted expansion of the
phenotypic and functional CD34+CD38− compartment
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seed sequence between species and is expressed in
hematopoietic cells at different stages from both mouse
and human origin, there still exist different opinions
concerning the function of miR-17 on hematopoiesis
[16, 21–23]. Our studies demonstrated that miR-17 may
specifically affect hematopoietic stem and early progeni-
tor cells. This idea is evidenced by the fact that ectopic
miR-17 promotes the proliferation of CB CD34+CD38−
cells, especially within the first 15 days of culture when
the cells are the least differentiated (Fig. 2b). The ex-
panded hematopoietic cells upon ectopic miR-17 can
promote myeloid lineage fate (Fig. 2c), which is consist-
ent with the results from Meenhuis group [19], demon-
strating the conservative function of miR-17 between
mouse and human HSC to a certain extent. It seems that
miR-17 has almost no effect on the erythroid lineage devel-
opment based on the lack of a significant difference be-
tween the number of BFU-E from 17/OE cells and that
from the CTRL cells. The function of miR-17 on human
CB CD34+ cells is reinforced by knockdown studies on
miR-17. Moreover, the expanded CB CD34+ cells by ec-
topic miR-17 are capable of normal maturation ex vivo be-
cause they could differentiate into all of the lineages tested.
17/KD CB CD34+ cells may have a higher engraftment
potential than CTRL CD34+ cells during the first 4 weeks
after transplantation because PB MNCs from 17/KD re-
cipients displayed a significantly higher percentage of
human CD45+ populations at 4 weeks compared with
that from the CTRL group (Fig. 3a, left panel). It is of
great interest to note that the hematopoietic reconstitu-
tion potential of miR-17 overexpressed CB CD34+ cells
in vivo is reduced compared to that of CTRL CB CD34+
cells according to SCID repopulating cells assays (Fig. 3).
miR-17 was speculated to promote the hematopoietic re-
constitution potential of CB CD34+ cells in vivo accord-
ing to our in vitro assay. We observed no significant
difference in the percentage of human erythroid cells,
including CD45−CD36+ and CD36−GPA+ populations in
the bone marrow of mice between the 17/OE and CTRL
groups, which is consistent with the colony forming
assay in vitro. However, a significantly lower percentage
of human CD45+ cells and CD45+CD34+ cells was ob-
served in the bone marrow of mice transplanted with
17/OE CD34+ cells compared to that in the bone mar-
row of mice transplanted with CTRL CD34+ cells. The
levels of miR-17 expression in GFP-positive cells from
engrafted mice at 20 weeks were still up- or downmo-
dulated (Fig. 3c), which indicated that this inconsist-
ency between the in vivo and in vitro data was not due
to the change of miR-17 expression in vivo. Successful
hematopoietic reconstitution of human HSCs in vivo
requires suitable attachment between HSCs and the
bone marrow niche, as well as migration betweenbones in engrafted mice. The mechanisms of engraftment
have revealed a host of contributing factors, including
adhesion molecules, such as integrins and CXCR4, as an
important homing factor for HSCs [32–34]. According
to our data, further studies are still needed to prove that
the interaction between 17/OE cells and their niche
cells in vivo is abnormal. However, compared to CTRL
cells, 17/OE cells did express significantly higher levels
of N-cadherin and β1-integrin (CD29) (Fig. 4), which
helps mediate the binding of HSCs to bone marrow
niche cells [35]. α5 (CD49e) and α4 (CD49d) integrins
were also slightly upregulated. Both N-cadherin and
CD29, together with other integrins and the chemokine
receptor CXCR4, are known to be expressed in human
HSCs and serve to promote their adhesion to the bone
marrow niche cells [34, 36–38]. In support of this find-
ing in vitro, a significant increase was observed in the
adhesion of CB CD34+ cells to N-cadherin and VCAM1
following miR-17 overexpression (Fig. 5a). This observa-
tion was further confirmed by knocking down the ex-
pression of β1-integrin in 17/OE CD34
+ cells, which
significantly reduced the adhesion potential of 17/OE
CD34+ cells to VCAM1 (Fig. 5b). The decreased adhe-
sion between β1/KD CB CD34
+ cells and VCAM1 raised
the possibility that the interaction between β1/KD CB
CD34+ cells and their niche was not as strong as that of
17/OE CD34+ cells in vivo. It seemed that the signifi-
cantly reduced hematopoietic reconstitution potential
of miR-17 overexpressed CB CD34+ cells in vivo is not a
result of the defect of transplanted 17/OE cell migration
between bones because the migration of miR-17 overex-
pressed CB CD34+ cells in vitro towards SDF1α was
only slightly increased compared to that of CTRL cells.
All of these results indicated that interaction of miR-17
overexpressed CB CD34+ cells with their niche may be
abnormal in vivo and further prevent the efficient and
continuous production of blood cells, which may be, at
least in part, responsible for the reduced hematopoietic
reconstitution potential of miR-17 overexpressed CB
CD34+ cells in vivo. The mechanisms underlying the en-
hanced expression of adhesive molecules in CB CD34+
cells upon ectopic miR-17 are largely unclear and will
be explored further in our laboratory.
Conclusions
In summary, our data suggest the potential contribution
of miR-17 in the in vitro and in vivo function on human
HSCs and HPCs. These data add adhesive molecules
to the signaling network affected by miR-17 and sug-
gest a miR-17–N-cadherin (β1-integrin) pathway in
human CB HSCs and HPCs. Therefore, further inves-
tigations of miR-17 on hematopoiesis in vivo raises the
possibility that miR-17 may play a wider role in regulating
hematopoietic development.
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Additional file 1: Figure S1. (A) The representative image of transfection
efficiency (percentage of GFP-positive cells) was shown when sorted through
FITC channel by FACS. The representative image of CFU-Mix (B), CFU-GM
(C) and BFU-E (D). (TIFF 409 kb)
Additional file 2: Figure S2. (A) Flow cytometry analysis of the
expression of GFP on CB CD34+CD38−/CD38+cells upon miR-17
modulation after culturing for 20 days (red line) and control cells (black
line). (B). The expression of N-cadherin and β1-integrin on CB CD34+ cells
after miR-17 knockdown (17/KD) or control cells (CTRL) was analyzed by
flow cytometry (left panels). The results are expressed as mean ± SD from
multiple independent experiments (right panels). (TIFF 318 kb)
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